Skip to content

Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration

Functional Benefit With ACRYSOF® Natural Chromophore

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02219997
Enrollment
90
Registered
2014-08-19
Start date
2014-10-31
Completion date
2015-03-31
Last updated
2016-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Cataract, Intraocular lens (IOL), AcrySof

Brief summary

The purpose of this study is to compare the reaction time (as measured by braking reaction time in seconds during simulated driving) under glare and no-glare conditions in subjects implanted with ACRYSOF® IQ intraocular lenses (IOLs) to subjects implanted with clear IOLs. This study will enroll subjects previously implanted with IOLs in both eyes for at least 3 months.

Detailed description

Subjects completed 2 visits to the investigational site.

Interventions

Clip-on glasses with no blue light filtering properties used as a placebo

Clip-on glasses with blue light filtering properties similar to ACRYSOF® IOLs

AcrySof IQ Aspheric Natural IOL Model SN60WF with UV and blue light filtering properties, previously implanted

DEVICEClear IOL

Clear IOL, previously implanted

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Pseudophakes with ACRYSOF® IQ monofocal IOLs or clear (no blue light filter) IOLs in both eyes for at least 3 months. * Willing and able to understand and sign an informed consent form. * Corrected visual acuity (CVA) of 20/40 or better. * Have a valid driver's license. * Depth perception of at least 100 arc seconds. * Other protocol-specified inclusion criteria may apply.

Exclusion criteria

* Ocular pathology, degeneration, or media opacity. * Color vision defect. * Use of ocular or systemic medications that impact macular pigment density or reaction time, including but not limited to, lutein, zeaxanthin, barbiturates, tranquilizers or amphetamines. * System conditions affecting connective tissue or sensory-motor coordination. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Change in Braking Reaction Time From No-glare to GlareVisit 2, up to Day 30Braking reaction time (time to brake, in seconds) was assessed using a driving simulator in no-glare and glare conditions. The subject was presented with a driving scenario during which an obstruction (car pulling over from either side of the road in a random fashion) was presented. Subjects braked in an attempt to avoid colliding with the obstruction, and the braking reaction time was recorded. The experiment was repeated with a glare source present. Both assessments (no-glare and glare) occurred on the same day. Change in braking reaction time was calculated as glare minus no-glare.

Secondary

MeasureTime frameDescription
Change in Braking Reaction Time From No-glare to Glare (Clear IOLs)Visit 2, Up to Day 30Braking reaction time (time to brake, in seconds) was assessed using a driving simulator in no-glare and glare conditions. The subject was presented with a driving scenario during which an obstruction (car pulling over from either side of the road in a random fashion) was presented. Subjects braked in an attempt to avoid colliding with the obstruction, and the braking reaction time was recorded. The experiment was repeated with a glare source present. Both assessments (no-glare and glare) occurred on the same day. Change in braking reaction time was calculated as glare minus no-glare. This outcome measure was pre-specified for Clear IOL only.
Change in Braking Reaction Time From No-glare to Glare (ACRYSOF® IQ IOL + Placebo Filter; Clear IOL + BLF)Visit 2, Up to Day 30Braking reaction time (time to brake, in seconds) was assessed using a driving simulator in no-glare and glare conditions. The subject was presented with a driving scenario during which an obstruction (car pulling over from either side of the road in a random fashion) was presented. Subjects braked in an attempt to avoid colliding with the obstruction, and the braking reaction time was recorded. The experiment was repeated with a glare source present. Both assessments (no-glare and glare) occurred on the same day. Change in braking reaction time was calculated as glare minus no-glare.

Participant flow

Recruitment details

Subjects were recruited from 6 study centers located in the US.

Pre-assignment details

Of the 90 enrolled, 22 subjects were exited prior to reaction testing. This reporting group includes all subjects who were reaction tested (68).

Participants by arm

ArmCount
AcrySof IQ IOL
ACRYSOF® IQ IOL with clear clip-on glasses worn for 3 hours
33
Clear IOL
Clear IOL with blue light filter clip-on glasses and clear clip-on glasses, worn in a cross-over fashion, as randomized, for 4 hours total
35
Total68

Baseline characteristics

CharacteristicAcrySof IQ IOLClear IOLTotal
Age, Continuous70.8 years
STANDARD_DEVIATION 3.2
70.3 years
STANDARD_DEVIATION 2.8
70.6 years
STANDARD_DEVIATION 3
Sex: Female, Male
Female
17 Participants21 Participants38 Participants
Sex: Female, Male
Male
16 Participants14 Participants30 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 900 / 330 / 35
serious
Total, serious adverse events
0 / 900 / 330 / 35

Outcome results

Primary

Change in Braking Reaction Time From No-glare to Glare

Braking reaction time (time to brake, in seconds) was assessed using a driving simulator in no-glare and glare conditions. The subject was presented with a driving scenario during which an obstruction (car pulling over from either side of the road in a random fashion) was presented. Subjects braked in an attempt to avoid colliding with the obstruction, and the braking reaction time was recorded. The experiment was repeated with a glare source present. Both assessments (no-glare and glare) occurred on the same day. Change in braking reaction time was calculated as glare minus no-glare.

Time frame: Visit 2, up to Day 30

Population: This analysis population includes subjects who were reaction tested with no major protocol violations (per protocol).

ArmMeasureValue (MEAN)Dispersion
AcrySof IQ IOLChange in Braking Reaction Time From No-glare to Glare0.07 secondsStandard Deviation 0.12
Clear IOLChange in Braking Reaction Time From No-glare to Glare0.15 secondsStandard Deviation 0.21
Secondary

Change in Braking Reaction Time From No-glare to Glare (ACRYSOF® IQ IOL + Placebo Filter; Clear IOL + BLF)

Braking reaction time (time to brake, in seconds) was assessed using a driving simulator in no-glare and glare conditions. The subject was presented with a driving scenario during which an obstruction (car pulling over from either side of the road in a random fashion) was presented. Subjects braked in an attempt to avoid colliding with the obstruction, and the braking reaction time was recorded. The experiment was repeated with a glare source present. Both assessments (no-glare and glare) occurred on the same day. Change in braking reaction time was calculated as glare minus no-glare.

Time frame: Visit 2, Up to Day 30

Population: This analysis population is a subset of all randomized subjects with no major protocol violations and had non-missing values at the specific time point for each arm, respectively.

ArmMeasureValue (MEAN)Dispersion
AcrySof IQ IOLChange in Braking Reaction Time From No-glare to Glare (ACRYSOF® IQ IOL + Placebo Filter; Clear IOL + BLF)0.12 secondsStandard Deviation 0.12
Clear IOLChange in Braking Reaction Time From No-glare to Glare (ACRYSOF® IQ IOL + Placebo Filter; Clear IOL + BLF)0.16 secondsStandard Deviation 0.2
Secondary

Change in Braking Reaction Time From No-glare to Glare (Clear IOLs)

Braking reaction time (time to brake, in seconds) was assessed using a driving simulator in no-glare and glare conditions. The subject was presented with a driving scenario during which an obstruction (car pulling over from either side of the road in a random fashion) was presented. Subjects braked in an attempt to avoid colliding with the obstruction, and the braking reaction time was recorded. The experiment was repeated with a glare source present. Both assessments (no-glare and glare) occurred on the same day. Change in braking reaction time was calculated as glare minus no-glare. This outcome measure was pre-specified for Clear IOL only.

Time frame: Visit 2, Up to Day 30

Population: This analysis population is a subset of all randomized subjects with no major protocol violations and had non-missing values at the specific time point for each arm, respectively.

ArmMeasureValue (MEAN)Dispersion
AcrySof IQ IOLChange in Braking Reaction Time From No-glare to Glare (Clear IOLs)0.17 secondsStandard Deviation 0.16
Clear IOLChange in Braking Reaction Time From No-glare to Glare (Clear IOLs)0.16 secondsStandard Deviation 0.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026